Assistant Professor @MassGenBrigham, asthma, genetics, microbiome, multi-omics, dad, husband, swimmer
Boston, MA
Joined May 2017
- Tweets464
- Following87
- Followers150
- Likes953
Zhaozhong Zhu retweeted
Everything you wanted to know about single cell multi-omics in one place- just published in ERJ
@ERSpublications
Our "Single-cell multi-omics in IPF & COPD: from atlas to impact" is out! We provide a brief guide to analytic approaches, an overview of how the technologies impact our understanding of the 2 diseases, limitations, future directions.
A 🧵 will follow
publications.ersnet.org/cont…
Zhaozhong Zhu retweeted
Last weekend I was at @PCRSUK with @FionaMosgrove and @paul_mccallion taking bronchiectasis . So important to link primary and secondary care ❤️
Zhaozhong Zhu retweeted
So great to see our review out 🤩🫁
Bronchiectasis is driven by dynamic host–microbiome interactions, not single pathogens. Integrating microbial and immune multi-omics can define actionable endotypes, enabling precision therapy and accelerating translation from discovery to clinical care. bit.ly/4xfavDv
Zhaozhong Zhu retweeted
Thanks Running on Air and NTMir for giving me a chance to talk to the patient community!
Let me know what you'd like to hear.
I'll cover all the latest news from ERS and answer any questions you have
Join Prof. James Chalmers for highlights from the ERS Congress in Barcelona!
Get the latest research and clinical breakthroughs in Bronchiectasis & NTM from the world's largest respiratory meeting
Learn more: bit.ly/2MenuSH
#ERSCongress #NTMAwareness #Bronchiectasis
Zhaozhong Zhu retweeted
Come on thursday to hear the AMAZING Emma Johnson, Me and Tim Aksamit talk about state of the art management of bronchiectasis
Chaired by the awesome Divya Reddy
Team bronchiectasis @ATS_PITB
🚨 Mark your calendars for our next
🌲PINE🌲 Webinar!
🫁 Bronchiectasis Management Reimagined: Key Updates from the 2025 ERS Guidelines
Case-based discussion with global experts 🌍
🗓️ Sep 17 |⏱️ 11 AM ET
📝 Register here: thoracic.zoom.us/webinar/reg…
@ATS_Assemblies @EuroRespSoc
Zhaozhong Zhu retweeted
Thanks for inviting me to do this
A special ERS congress because patients were at the heart of every session ❤️
💙 Patient voices took centre stage at #ERSCongress2026.
Our four patient-centred studio sessions explored lived experience, patient involvement in research, health inequalities and stigma, all through the lens of partnership.
👉 europeanlung.org/en/news-and…
Zhaozhong Zhu retweeted
First day and already I know this will be my favourite session of the congress
Thank you to all of our patients and tk @EuropeanLung - you’ve changed the clinical and scientific landscape in bronchiectasis and many other respiratory diseases ❤️
💙 Thank you to everyone who made #ELFPatientOrgDay2026 such a success!
Speakers, chairs and attendees from ERS and across our network shared experiences and ideas, highlighting the power of patient-professional collaboration.
#ERSCongress2026 #PatientVoice @EuroRespSoc 🫁💙
Zhaozhong Zhu retweeted
What a fantastic third day we’ve had here at #ERSCongress2026!
Thank you to everyone who joined us for another brilliant day. We look forward to seeing you tomorrow!
#ERSCongress #Barcelona
Zhaozhong Zhu retweeted
Azithromycin treatment enhanced epithelial IFN–β/λ responses and reduced IL–33 concentration after rhinovirus infection in asthma – dual effects supporting its role in boosting antiviral immunity and reducing type 2 inflammation to prevent exacerbations bit.ly/4mcISFS
Zhaozhong Zhu retweeted
Podcast August 2026: Fentanyl or morphine or placebo for persistent dyspnoea in #COPD. "There is an effect of morphine or opioids on breathlessness, but it does not translate in a relevant and significant effect in daily life treatment..." publications.ersnet.org/cont…
Zhaozhong Zhu retweeted
Very excited for this study to be out. In this study, we looked to evaluate the epidemiology of bronchiectasis in Alberta; representing the first population based study of adults in bronchiectasis in Canada. 🇨🇦 🫁 @UCalgaryMed @SnyderInstitute
academic.oup.com/annalsats/a…
Zhaozhong Zhu retweeted
Further evidence of the challenges in targeting the mighty neutrophil.
Our trial of Myeloperoxidase (MPO) inhibition in COPD found no efficacy, and increased pneumonia
Just published in @ERSpublications
publications.ersnet.org/cont…
Zhaozhong Zhu retweeted
The Chalmers laboratory at the University of Oxford is looking for an outstanding postdoctoral research to lead an ambitious research project to find new therapies targeting mucus/MUC5AC in bronchiectasis
We are a supportive and friendly team
Apply now!
my.corehr.com/pls/uoxrecruit…
Zhaozhong Zhu retweeted
⏳ Only one week left to vote for the next ERS Vice President!
🗳️ Members have until Sunday, 2 August 2026 (23:59 CEST) to cast their vote via the 'Elections' tab on myERS: my.ersnet.org/
Zhaozhong Zhu retweeted
join us for World bronchiectasis day!
📢 Register now for our #WorldBronchiectasisDay Question Time!
Join us on 1 July as physiotherapists, patients and experts answer your questions about airway clearance and bronchiectasis.
🔗 europeanlung.org/en/get-invo…
@EuroRespSoc
Zhaozhong Zhu retweeted
A primary care summary of the European Respiratory Society guidelines for bronchiectasis 2025
A collaboration with GP colleagues to improve the quality of care for people with bronchiectasis in primary care
@FionaMosgrove @MereteLong @AlibertiStefano
nature.com/articles/s41533-0…
Zhaozhong Zhu retweeted
Large scale proteomics reveal new biomarkers and therapeutic targets in #COPD. What are these biomarkers? Many in the metabolic pathway. Why? Here Xuekui and I go into the reasons behind this observation bit.ly/4t12i3u
Zhaozhong Zhu retweeted
The European Respiratory Journal impact factor, released today, has increased to 23.8, its highest ever level outside of the COVID-19 pandemic.
We are incredibly proud of the high scientific impact of the ERJ @ERSpublications and very grateful to authors, reviewers, our outstanding publication office team and our outstanding editors.
Respiratory Journal IFs
Lancet Resp 34.7
ERJ 23.8
Journal of thoracic Oncology 23.3
AJRCCM 21.7
ERR 10.8
CHEST 9.8
Thorax 9.1
@EuroRespSoc @donsin4
Zhaozhong Zhu retweeted
Join my new group at the University of Oxford! We are looking for a data analyst to examine our world leading EMBARC database. Work with experts to find new insights in lung disease with big data!
Join us!
my.corehr.com/pls/uoxrecruit…
@MereteLong @beccahull_
Zhaozhong Zhu retweeted
Get involved in the exciting world of respiratory research
The Chalmers laboratory at University of Oxford is looking for a senior research technician
Work on world leading translational research in a supportive team
Join us!
my.corehr.com/pls/uoxrecruit…
